Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Weaver

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 4, 2010
Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effectsCaroline O Cobb, Alan Shihadeh, Michael F Weaver, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 8, 2008
Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokersMelissa D Blank, Cynthia Sams, Michael F Weaver, et al.
Journal of Addictive Diseases|June 21, 2006
Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidityMichael F Weaver, Heather J Hoffman, Robert E Johnson, et al.
Journal of Addiction Medicine|August 14, 2023
Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series StudyLuba Yammine, Jessica C Balderas, Michael F Weaver, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effectsAndrea R Vansickel, Caroline O Cobb, Michael F Weaver, et al.
Journal of Addiction Medicine|March 18, 2024
E-cigarettes and Youth: The Known, the Unknown, and Implications for StakeholdersLuba Yammine, Maria Tovar, Nastassia Anna Yammine, et al.
Experimental and Clinical Psychopharmacology|June 8, 2006
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' genderSarah E Evans, Melissa Blank, Cynthia Sams, et al.
Experimental and Clinical Psychopharmacology|May 21, 2008
The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and menBethea A Kleykamp, Janine M Jennings, Cynthia Sams, et al.
American Journal of Health Behavior|August 9, 2006
Aberrant drug-taking behaviors and headache: patient versus physician reportMichael F Weaver, Dale S Bond, Brent L Arnold, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 30, 2006
Expired carbon monoxide levels in self-reported smokers and nonsmokers in prisonKaren L Cropsey, Gloria D Eldridge, Michael F Weaver, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 4, 2010
Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effectsCaroline O Cobb, Alan Shihadeh, Michael F Weaver, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 8, 2008
Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokersMelissa D Blank, Cynthia Sams, Michael F Weaver, et al.
Journal of Addictive Diseases|June 21, 2006
Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidityMichael F Weaver, Heather J Hoffman, Robert E Johnson, et al.
Journal of Addiction Medicine|August 14, 2023
Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series StudyLuba Yammine, Jessica C Balderas, Michael F Weaver, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effectsAndrea R Vansickel, Caroline O Cobb, Michael F Weaver, et al.
Journal of Addiction Medicine|March 18, 2024
E-cigarettes and Youth: The Known, the Unknown, and Implications for StakeholdersLuba Yammine, Maria Tovar, Nastassia Anna Yammine, et al.
Experimental and Clinical Psychopharmacology|June 8, 2006
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' genderSarah E Evans, Melissa Blank, Cynthia Sams, et al.
Experimental and Clinical Psychopharmacology|May 21, 2008
The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and menBethea A Kleykamp, Janine M Jennings, Cynthia Sams, et al.
American Journal of Health Behavior|August 9, 2006
Aberrant drug-taking behaviors and headache: patient versus physician reportMichael F Weaver, Dale S Bond, Brent L Arnold, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 30, 2006
Expired carbon monoxide levels in self-reported smokers and nonsmokers in prisonKaren L Cropsey, Gloria D Eldridge, Michael F Weaver, et al.
Pageof 5